Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a slightly lower threshold for treating low blood sugar prevent dangerous spikes in kids with diabetes?

NCT ID NCT07711275

Completed Disease control Sponsor: Marmara University Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 21, 2026 · Updated 2 times

Summary

This study tests whether treating low blood sugar (hypoglycemia) at a slightly lower threshold of 65 mg/dL, instead of the standard 70 mg/dL, can prevent rebound high blood sugar in children with type 1 diabetes. Each child undergoes both approaches in a crossover design, receiving sugar cubes followed by complex carbohydrates. The goal is to see which threshold leads to better blood sugar control two hours after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
simple carbohydrates (sugar cubes) and complex carbohydrates (quinoa, black cumin, bran, oat crackers)
What this could lead to
If successful, this could lead to a refined guideline for treating low blood sugar in children with type 1 diabetes, potentially reducing dangerous spikes afterward.
What could go wrong
This is a small, early-stage trial with only 33 children, so results may not apply to all. The approach is a minor adjustment to standard care, not a breakthrough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperglycemia hypoglycemia type 1 diabetes mellitus type 1 diabetes mellitus 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 1

Contacts and locations

Locations

  • Marmara University

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.